Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cerilliant
Teva
Federal Trade Commission
Johnson and Johnson
Mallinckrodt
Express Scripts
Cantor Fitzgerald
Deloitte
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

PHENYLBUTAZONE - Generic Drug Details

« Back to Dashboard

Medical Subject Heading (MeSH) Categories for PHENYLBUTAZONE

US Patents and Regulatory Information for PHENYLBUTAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries PHENYLBUTAZONE phenylbutazone TABLET;ORAL 088863-001 Dec 4, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 088994-001 Dec 4, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 088218-001 Jun 24, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENYLBUTAZONE phenylbutazone TABLET;ORAL 084339-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENYLBUTAZONE phenylbutazone CAPSULE;ORAL 087774-001 Jun 16, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us AZOLID phenylbutazone CAPSULE;ORAL 087260-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis BUTAZOLIDIN phenylbutazone TABLET;ORAL 008319-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PHENYLBUTAZONE phenylbutazone TABLET;ORAL 086151-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PHENYLBUTAZONE phenylbutazone TABLET;ORAL 087674-001 Apr 21, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis BUTAZOLIDIN phenylbutazone CAPSULE;ORAL 008319-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
UBS
Merck
Accenture
Fish and Richardson
Johnson and Johnson
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot